Serotonin syndrome presenting as hypotonic coma and apnea: potentially fatal complications of selective serotonin receptor inhibitor therapy.
OBJECTIVE
To describe a patient who developed serotonin syndrome on four separate occasions as a result of monotherapy with two different selective serotonin receptor inhibitors (fluoxetine and cetalopram).


METHODS
Case report.


METHODS
Community hospital.


METHODS
Single patient with four episodes of serotonin syndrome.


RESULTS
The syndrome was characterized by coma/unresponsiveness (four episodes), dilated pupils (four episodes), salivation (two episodes), dryness of mouth (two episodes), myoclonus like activity of eyelids (four episodes), oculogyric crisis (four episodes), flaccid paralysis of all extremities (four episodes), tremors (two episodes), apnea (two episodes), restlessness (one episode). Recovery occurred within 24 hrs, although muscle pain and weakness persisted for 2 months after stopping fluoxetine. Apnea occurred in both episodes associated with fluoxetine therapy.


CONCLUSIONS
Apnea and coma may occur in serotonin syndrome.
Chechani
Vijay
V
Covenant Family Healthcare, Roswell, NM 88201, USA.
D000328:Adult; D001049:Apnea / Q000139:chemically induced*; D003128:Coma / Q000139:chemically induced*; D005260:Female; D005473:Fluoxetine / Q000009:adverse effects*; D006801:Humans; D017366:Serotonin Receptor Agonists / Q000009:adverse effects*; D020230:Serotonin Syndrome / Q000175:diagnosis* / Q000209:etiology / Q000503:physiopathology
D017366:Serotonin Receptor Agonists; D005473:Fluoxetine